ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDP Indaptus Therapeutics Inc

2.15
0.065 (3.12%)
After Hours
Last Updated: 19:11:36
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Indaptus Therapeutics Inc INDP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.065 3.12% 2.15 19:11:36
Open Price Low Price High Price Close Price Prev Close
2.09 2.09 2.1854 2.15 2.085
more quote information »

Recent News

Date Time Source Heading
5/08/202408:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202408:05EDGAR2Form 8-K - Current report
5/08/202408:00GLOBEIndaptus Therapeutics Reports First Quarter 2024 Financial..
4/11/202407:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
3/28/202408:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
3/25/202408:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
3/18/202408:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
3/13/202407:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
3/04/202411:01EDGAR2Form 8-K - Current report
3/04/202407:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
2/15/202408:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
2/08/202408:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
1/23/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:05EDGAR2Form 8-K - Current report
1/04/202408:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
11/06/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:05EDGAR2Form 8-K - Current report
11/06/202316:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
11/06/202308:13EDGAR2Form 8-K - Current report
11/06/202308:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
10/31/202309:12EDGAR2Form 8-K - Current report
10/31/202309:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
9/27/202308:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
9/26/202308:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
9/19/202308:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
9/06/202308:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
8/16/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202308:10EDGAR2Form 8-K - Current report
8/14/202308:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
8/10/202308:45EDGAR2Form 8-K - Current report
8/10/202308:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
8/07/202308:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
6/15/202308:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..
5/31/202308:30GLOBEIndaptus Therapeutics to Present at the Jefferies Healthcare..

Your Recent History

Delayed Upgrade Clock